Issues related to prescription drug pricing; Issues related to Section 340B of the Public Health Service Act (PL 78-410); Drug pricing issues related to the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to flu and RSV vaccines.
Source-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 16, 2025
- Income
- $50,000.00
- Expenses
- Not reported
- Registrant
- FORBES-TATE
- Client
- SANOFI U.S.
- Filing UUID
- 6093d0be-328c-4119-a269-9b911ba92ed8
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to prescription drug pricing, including the implementation of the Inflation Reduction Act of 2022 (PL 117-169); Issues related to Section 340B of the Public Health Service Act (PL 78-410); Issues related to pharmacy benefit managers.
Issues related to orphan drug tax credit; Issues related to the excise tax for the Vaccine Injury Compensation Fund.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.